Health Is Cure · 11:38 06 Oct 2023
More than 40% of patients with muscle-invasive bladder cancer (MIBC) avoided immediate cystectomy after achieving a clinical complete response (cCR) with a chemoimmunotherapy combination… Read More
Chemoimmunotherapy Blog Posts
Health Is Cure · 15:35 24 Aug 2023
Chemoimmunotherapy for untreated lung cancer brain metastases delayed progression and use of whole-brain radiation, a prospective phase II study showed.
Atezolizumab (Tecentriq) plus carbo… Read More
Health Is Cure · 17:19 05 Sep 2023
Adding regorafenib (Stivarga) to a standard first-line chemoimmunotherapy regimen for HER2-negative metastatic esophagogastric cancer demonstrated “promising” activity in a sin… Read More
Healthy Insights · 08:58 20 Jun 2023
Chemoimmunotherapy Responses May Allow for Omission of Radiotherapy in LymphomaRadiotherapy has long been an integral part of the treatment regimen for lymphoma, a type of cancer that… Read More
Health Is Cure · 11:01 22 Jun 2023
Treatment with the chimeric antigen receptor (CAR) T-cell therapy axicabtagene ciloleucel (axi-cel; Yescarta) resulted in significantly improved overall survival compared with the current… Read More
Health Is Cure · 10:38 07 Jun 2023
CHICAGO — In patients with metastatic EGFR-positive lung cancer who progressed on targeted agents, adding pembrolizumab (Keytruda) to a standard chemotherapy regimen demonstrated n… Read More
Health Is Cure · 17:24 05 Jun 2023
CHICAGO — Patients treated with the chimeric antigen receptor (CAR) T-cell therapy axicabtagene ciloleucel (axi-cel; Yescarta) in the second line for early relapsed or refractory l… Read More
Personalized Content… · 14:56 25 May 2023
The US Food and Drug Administration (FDA) has granted approval to AbbVie and Genmab’s Epkinly (epcoritamab-bysp) as the first and only T-cell engaging bispecific antibody for the treat… Read More
Health Is Cure · 21:10 24 Apr 2023
Adding an investigational anti-PD-1 drug to perioperative chemotherapy improved event-free survival (EFS) in patients with resectable, stage III non-small cell lung cancer (NSCLC), an inte… Read More
Market Research & Ma… · 23:22 02 Feb 2023
The “Chimeric Antigen Receptor T-Cell Therapy Pipeline Insight, 2023,” report provides comprehensive insights about 300+ companies and 300+ pipeline drugs in Chimeric Antigen Re… Read More
India Paint Industry… · 04:34 10 Dec 2022
Bharat Book Bureau Provides the Trending Market Research Report on “Global CAR T Cell Therapy Market & Clinical Trials Insight 2028” under the Life Sciences Market Research R… Read More
Cnn Wolrd Today · 11:00 16 Sep 2022
SANTA MONICA, Calif.–(BUSINESS WIRE)–Kite, a Gilead Company (Nasdaq: GILD), today announces that the European Medicines Agency (EMA) Committee for Medicinal Products for Human… Read More
Personalized Content… · 21:42 29 Jun 2022
The new FDA approval gives Breyanzi (lisocabtagene maraleucel) the broadest patient eligibility of any CAR T-cell therapy in relapsed or refractory LBCL. Product logo and product image court… Read More
Mottocosmos.com | Wo… · 14:03 13 Apr 2022
My wife's lymphoma diagnosis and 50th birthday came on the same day in March 2021. Rebecca had been aggressively chasing the cause of the small lump she found in her abdomen. With access to… Read More
Newsfile Corp News R… · 13:00 30 Aug 2021
Vancouver, British Columbia--(Newsfile Corp. - August 30, 2021) - BioCure Technology Inc. (CSE: CURE) (OTCQB: BICTF) (FSE: 1WH) ("BioCure" or the "Company") is pleased to provide the followi… Read More
Stl.news · 09:45 11 Jun 2019
Silver Spring, MD (STL.News) – Yesterday, the U.S. Food and Drug Administration granted accelerated approval to Polivy (polatuzumab vedotin-piiq), in combination with the chemotherapy… Read More
Acute Market Insight… · 05:25 25 Jul 2018
Report Name: AbbVie Inc. Profile – Overview, History, SWOT Analysis, Products/Services, Facts, Financials, Key Executives, Competitors, Tech Intelligence, IT Outsourcing, IT Mana… Read More